Thromb Haemost 2007; 97(04): 617-626
DOI: 10.1160/TH06-11-0640
Wound Healing and Inflammation/Infection
Schattauer GmbH

Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells

Ruth Heying
1   Department of Paediatric Cardiology, University Children's Hospital, Duesseldorf, Germany
2   Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
,
Joke van de Gevel
2   Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
,
Yok-Ai Que
3   Division of Critical Care Medicine, Internal Medicine Department, CHUV, Lausanne, Switzerland
,
Philippe Moreillon
4   Institute of Fundamental Microbiology, UNIL, Lausanne, Switzerland
,
Henry Beekhuizen
2   Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
› Author Affiliations
Financial support: This work was in part supported by a grant from the German Society of Cardiology, Duesseldorf, Germany.
Further Information

Publication History

Received 10 November 2006

Accepted after resubmission 15 February 2007

Publication Date:
24 November 2017 (online)

Summary

Surface molecules of Staphylococcus aureus are involved in the colonization of vascular endothelium which is a crucial primary event in the pathogenesis of infective endocarditis (IE).The ability of these molecules to also launch endothelial procoagulant and proinflammatory responses, which characterize IE, is not known. In the present study we investigated the individual capacities of three prominent S. aureus surface molecules; fibronectinbinding protein A (FnBPA) and B (FnBPB) and clumping factor A (ClfA), to promote bacterial adherence to cultured human endothelial cells (ECs) and to activate phenotypic and functional changes in these ECs. Non-invasive surrogate bacterium Lactococcus lactis, which, by gene transfer, expressed staphylococcal FnBPA, FnBPB or ClfA molecules were used. Infection of ECs increased 50- to 100-fold with FnBPA- or FnBPB-positive recombinant lactococci. This coincided with EC activation, interleukin- 8 secretion and surface expression of ICAM-1 andVCAM-1 and concomitant monocyte adhesion. Infection with ClfA-positive lactococci did not activate EC. FnBPA-positive L. lactis also induced a prominent tissue factor-dependent endothelial coagulation response that was intensified by cell-bound monocytes. Thus S. aureus FnBPs, but not ClfA, confer invasiveness and pathogenicity to non-pathogenic L. lactis organisms indicating that bacterium-EC interactions mediated by these adhesins are sufficient to evoke inflammation as well as procoagulant activity at infected endovascular sites.

 
  • References

  • 1 Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
  • 2 Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363: 139-149.
  • 3 Hauck CR, Ohlsen K. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol 2006; 9: 5-11.
  • 4 Menzies BE. The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis 2003; 16: 225-229.
  • 5 Sinha B, Francois P, Que YA. et al. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun 2000; 68: 6871-6878.
  • 6 Schwarz-Linek U, Hook M, Potts JR. Fibronectinbinding proteins of Gram-positive cocci. Microbes Infect 2006; 8: 2291-2298.
  • 7 McDevitt D, Francois P, Vaudaux P. et al. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994; 11: 237-248.
  • 8 Hall AE, Domanski PJ, Patel PR. et al. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun 2003; 71: 6864-6870.
  • 9 Massey RC, Kantzanou MN, Fowler T. et al. Fibronectin- binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell Microbiol 2001; 3: 839-851.
  • 10 Fowler T, Wann ER, Joh D. et al. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol 2000; 79: 672-679.
  • 11 Peacock SJ, Foster TJ, Cameron BJ. et al. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology 1999; 145: 3477-3486.
  • 12 Sinha B, Francois PP, Nusse O. et al. Fibronectinbinding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol 1999; 1: 101-117.
  • 13 Kerdudou S, Laschke MW, Sinha B. et al. Fibronectin binding proteins contribute to the adherence of Staphylococcus aureus to intact endothelium in vivo. Thromb Haemost 2006; 96: 183-189.
  • 14 McDevitt D, Nanavaty T, House-Pompeo K. et al. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem 1997; 247: 416-424.
  • 15 Loughman A, Fitzgerald JR, Brennan MP. et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 2005; 57: 804-818.
  • 16 Suehiro K, Gailit J, Plow EF. Fibrinogen is a ligand for integrin alpha5beta1 on endothelial cells. J Biol Chem 1997; 272: 5360-5366.
  • 17 Sinha B, Herrmann M. Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thromb Haemost 2005; 94: 266-277.
  • 18 Que YA, Francois P, Haefliger JA. et al. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect Immun 2001; 69: 6296-6302.
  • 19 Schröder A, Schröder B, Roppenser B. et al. Staphylococcus aureus fibronectin binding protein-A induces motile attachment sites and complex actin remodeling in living endothelial cells. Mol Biol Cell 2006; 17: 5198-5210.
  • 20 Que YA, Haefliger JA, Piroth L. et al. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005; 201: 1627-1635.
  • 21 Veltrop MH, Beekhuizen H. Monocytes maintain tissue factor activity after cytolysis of bacteria-infected endothelial cells in an in vitro model of bacterial endocarditis. J Infect Dis 2002; 186: 1145-1154.
  • 22 Veltrop MH, Beekhuizen H, Thompson J. Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells. Infect Immun 1999; 67: 6130-6138.
  • 23 Beekhuizen H, van de Gevel JS, Olsson B. et al. Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J Immunol 1997; 158: 774-782.
  • 24 Veltrop MH, Thompson J, Beekhuizen H. Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells. Infect Immun 2001; 69: 2797-2807.
  • 25 Tekstra J, Beekhuizen H, Van De Gevel JS. et al. Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis. Clin Exp Immunol 1999; 117: 489-495.
  • 26 Matussek A, Strindhall J, Stark L. et al. Infection of human endothelial cells with Staphylococcus aureus induces transcription of genes encoding an innate immunity response. Scand J Immunol 2005; 61: 536-544.
  • 27 Veltrop MH, Bancsi MJ, Bertina RM. et al. Role of monocytes in experimental Staphylococcus aureus endocarditis. Infect Immun 2000; 68: 4818-4821.
  • 28 Que YA, Haefliger JA, Francioli P. et al. Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect Immun 2000; 68: 3516-3522.
  • 29 Peacock SJ, Day NP, Thomas MG. et al. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin. J Infect 2000; 41: 23-31.
  • 30 Beekhuizen H, Corsel-van Tilburg AJ, van Furth R. Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J Immunol 1990; 145: 510-518.
  • 31 Bancsi MJ, Thompson J, Bertina RM. Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun 1994; 62: 5669-5672.
  • 32 Wann ER, Gurusiddappa S, Hook M. The fibronectin- binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem 2000; 275: 13863-13871.
  • 33 Fitzgerald JR, Loughman A, Keane F. et al. Fibronectin- binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol 2006; 59: 212-230.